Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan

OBJECTIVE: Previous Western studies reported that older (≥50 years) breast cancer survivors with tamoxifen treatment had higher risk of endometrial cancer. This study aims to disclose whether younger (<50 years) tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Sung-Chao, Hsieh, Chia-Jung, Wang, Tso-Fu, Hong, Mun-Kun, Chu, Tang-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137368/
https://www.ncbi.nlm.nih.gov/pubmed/32269951
http://dx.doi.org/10.4103/tcmj.tcmj_17_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137368/
https://www.ncbi.nlm.nih.gov/pubmed/32269951
http://dx.doi.org/10.4103/tcmj.tcmj_17_19

Ejemplares similares